Monday, March 09, 2020

Informa Connect – CBI’s PCC 2020 – The 17th Annual Pharmaceutical Compliance Congress

Informa Connect – CBI’s PCC 2020 – The 17th Annual Pharmaceutical Compliance Congress
April 29 – May 1, 2020 | Grand Hyatt | Washington, DC
www.informaconnect.com/pcc

PCC 2020 – The 17th Annual Pharmaceutical Compliance Congress, taking place April 29-May 1, 2020 in Washington, DC, unites more than 500 bio/pharma professionals with responsibilities for compliance, ethics, legal affairs, commercial operations and patient support programs.

Exclusive Offer – use promo code PCCDC5 and save $500 if you register by March 27, 2020.*

The jam-packed, customizable agenda delivers innovative strategies to address the many emerging, high-risk areas impacting the industry today, including:
  • Hub and SP oversight
  • PAPs, PSPs and coupons
  • Drug pricing
  • Speaker programs
  • Data privacy
  • Medical and clinical affairs oversight
  • HCP engagement
  • Auditing and monitoring
  • Field compliance
  • And much more
Additional Congress highlights include:
  • 100+ expert speakers
  • Customizable programming featuring 18 workshops, 6 summits and 5 tracks
  • Enforcement insights from FDA, OIG, SEC and DOJ, with representation from six U.S. Attorneys
  • A “chasing miracles – when drug research is personal” chat with Amicus Therapeutics’ CEO and CRO on the criticality of compliance in advancing lifesaving therapies
  • An inside account from a former sales rep charged with violating the Anti-Kickback Statute
  • CLE, CPE and CCB-accredited** content
Save $500 if you use promo code PCCDC5 and register by March 27, 2020. Learn more at www.informaconnect.com/pcc.

*Discount offer valid through 3/27/2020; applies to standard rates only and may not be combined with other offers, categories, promotions or applied to an existing registration.
**Pending approval



The content of Sponsored Posts does not necessarily reflect the views of Pembroke Consulting, Inc., Drug Channels, or any of its employees.

No comments:

Post a Comment